BloomH. J. G., DukesC. E., MitchleyB. C. V.: Hormone dependent tumors of the kidney. I. Estrogen-induced renal tumor of the Syrian hamster. Hormone treatment and possible relationship to carcinoma of the kidney in man. Brit. J. Cancer., 17; 611 (1963).
2.
BloomH. J. G., WallaceD. M.: Hormones in the kidney: possible therapeutic role of testosterone in a patient with regression of metastases from renal adenocarcinoma. Brit. med. J., 2; 476–480 (1964).
3.
BloomH. J. G.: Adjuvant therapy for adenocarcinoma of the kidney: present position and prospects. Brit. J. Urol., 45; 237 (1973).
4.
BloomH. J. G.: Hormone induced and spontaneous regression of metastatic renal cancer. Cancer, 32; 1066 (1973).
5.
BonoA. V., BenvenutiC., GianneoF., ComeriG. C., RoggiaA.: Progesteron in renal cell carcinoma. A retrospective study. Eur. Urol., 5; 94 (1979).
6.
BracciU., Di SilverioF.: Attuali orientamenti nella diagnosi e terapia del carcinoma del rene. Atti Soc. Ital. Urol., 1; 147 (1976).
7.
ConcolinoG., Di SilverioF., MarocchiA., BracciU.: Renal cancer steroid receptors: biochemical basis for endocrine therapy. Eur. Urol., 5; 319 (1979).
8.
KirkmanH.: Estrogen-induced tumors of the kidney in the Syrian hamster. Nat. Cancer Inst. Monog., 1; 1 (1959).
9.
MortelR., LevyC., WolffJ. P., NicolasJ. C., RobelP., BaulieuE. E.: Female sex steroid receptors in post-menopausal endometrial carcinoma and biochemical response to an antiestrogen-Cancer Res., 41; 1140 (1981).
10.
MukamelE., BruhisS., NissenkornL., ServadioC.: Steroid receptors in renal cell carcinoma: relevance to hormone therapy. J. Urol., 131; 227 (1984).
11.
NakanoE., TadaY., FujiokaH., MatsudaM.: Hormone receptor in renal cell carcinoma and correlation with clinical response to endocrine therapy. J. Urol., 132; 240 (1984).
12.
NamerM., LaianneC., BaulieuE. E.: Increase of progesterone receptor by tamoxifene as a hormonal challenge test in breast cancer. Cancer Res., 40; 1750 (1980).
13.
PizzoccaroG., Di FronzoG., CappellettiV., PivaL.: Hormone treatment and sex steroid receptors in metastatic renal cell carcinoma: report of a multicentric prospective study. Tumori, 69; 215 (1983).
14.
RonchiE., PizzoccaroG., MiodiniP., PivaL., SalvioniR., Di FronzoG.: Steroid hormone receptors in normal and malignant human renal tissue: relationship with progestin therapy. J. Steroid Biochem., 21; 329 (1984).
15.
SatomiY., TakaiS., KondoI., FukushimaS., FuruhataA.: Postoperative prophylactic use of progesterone in renal cell carcinoma. J. Urol., 128; 919 (1982).